Notice 2023-52, page 650.

Section 5000D of the Internal Revenue Code imposes an excise tax on certain sales of certain drugs by manufacturers, producers, and importers of the drugs. Notice 2023-52 announces that the Treasury Department and IRS intend to issue proposed regulations under section 5000D. Specifically, the notice proposes that future regulations will provide:

(1) rules on the scope of sales subject to the section 5000D tax; (2) rules regarding the taxable sale price; and (3) procedural rules intended to help taxpayers meet their reporting and payment obligations with respect to the tax.